The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Galectin Therapeutics Inc

Nasdaq: GALT
Last

(U.S.) $1.91

Today's change+0.03 +1.60%
Updated September 22 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Galectin Therapeutics Inc

Nasdaq: GALT
Last

(U.S.) $1.91

Today's change+0.03 +1.60%
Updated September 22 4:00 PM -4GMT. Delayed by at least 15 minutes.

Galectin Therapeutics Inc crosses above 50-day moving average

Galectin Therapeutics Inc closed up sharply Friday, rallying (U.S.)$0.03 or 1.60% to (U.S.)$1.91 and crossing above its 50-day moving average. Over the last five days, shares have gained 9.14% and 94.94% year to date. Shares have underperformed the S&P 500 by 48.38% during the last year.

Key company metrics

  • Open(U.S.) $1.91
  • Previous close(U.S.) $1.88
  • High(U.S.) $2.00
  • Low(U.S.) $1.88
  • Bid / Ask-- / --
  • YTD % change+94.94%
  • Volume99,410
  • Average volume (10-day)165,514
  • Average volume (1-month)129,139
  • Average volume (3-month)156,186
  • 52-week range(U.S.) $0.49 to (U.S.) $3.68
  • Beta2.61
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.62
Updated September 22 4:00 PM -4GMT. Delayed by at least 15 minutes.

Latest Company News

    No News Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense5555
Selling / general / administrative1111
Research & development3433
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-5-5-5-5
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-5-5-5-5
Income after tax-5-5-5-5
Income tax, total--------
Net income-5-5-5-5
Total adjustments to net income001-1
Net income before extra. items-5-5-5-5
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-5-5-4-6
Inc. avail. to common incl. extra. items-5-5-4-6
Diluted net income-5-5-4-6
Dilution adjustment--------
Diluted weighted average shares35343029
Diluted EPS excluding extraordinary itemsvalue per share-0.14-0.15-0.13-0.19
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.14-0.15-0.13-0.19